Literature DB >> 32036675

State of art and advances on the treatment of bone metastases from breast cancer: a concise review.

Lorenzo Rossi1, Claudio Longhitano2, Florenc Kola3, Maria Del Grande4.   

Abstract

Bone is one of the most common metastatic sites in metastatic breast cancer (mBC). The presence of bone metastases can lead to various complications including pain, spinal cord compression, hypercalcaemia, pathological fractures. The treatment of bone metastases of breast cancer (BC) is mainly based on the biological characteristics of the primary tumour, but there are also specific treatments for bone lesions including bone modifiers, radionuclides, or localized treatments such as radiotherapy, surgery or vertebroplasty. In this review, we analyse the state of art of the common treatments and the advances of bone metastases of BC. Finally, we summarize the state of art of biomarkers in diagnosis, prognosis and prediction to therapy.

Entities:  

Keywords:  Breast cancer (BC); biomarkers; bisphosphonates; bone metastases; denosumab

Mesh:

Year:  2020        PMID: 32036675     DOI: 10.21037/cco.2020.01.07

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  6 in total

1.  EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation.

Authors:  Lin Zhang; Jingkun Qu; Yutao Qi; Yimin Duan; Yu-Wen Huang; Zhifen Zhou; Ping Li; Jun Yao; Beibei Huang; Shuxing Zhang; Dihua Yu
Journal:  Nat Commun       Date:  2022-05-10       Impact factor: 17.694

2.  Is it sufficient to evaluate metastatic bone involvement in breast cancer using SPECT/CT? A new approach of SPECT/CT-guided targeted bone marrow biopsy.

Authors:  Xiaomin Li; Caixia An; Wanchun Zhang
Journal:  BMC Cancer       Date:  2022-06-04       Impact factor: 4.638

3.  Preventing tumor progression to the bone by induced tumor-suppressing MSCs.

Authors:  Xun Sun; Kexin Li; Rongrong Zha; Shengzhi Liu; Yao Fan; Di Wu; Misato Hase; Uma K Aryal; Chien-Chi Lin; Bai-Yan Li; Hiroki Yokota
Journal:  Theranostics       Date:  2021-03-05       Impact factor: 11.600

4.  The prognostic role of surgery and a nomogram to predict the survival of stage IV breast cancer patients.

Authors:  Xinran Liu; Chengshi Wang; Yu Feng; Chaoyong Shen; Tao He; Zhu Wang; Linjie Ma; Zhenggui Du
Journal:  Gland Surg       Date:  2022-07

5.  Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast Cancer.

Authors:  Lina Marie; Dina Braik; Nayef Abdel-Razeq; Hala Abu-Fares; Ahmad Al-Thunaibat; Hikmat Abdel-Razeq
Journal:  Cancer Manag Res       Date:  2022-08-23       Impact factor: 3.602

6.  Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients.

Authors:  Nils Martin Bruckmann; Julian Kirchner; Lale Umutlu; Wolfgang Peter Fendler; Robert Seifert; Ken Herrmann; Ann-Kathrin Bittner; Oliver Hoffmann; Svjetlana Mohrmann; Christina Antke; Lars Schimmöller; Marc Ingenwerth; Katharina Breuckmann; Andreas Stang; Christian Buchbender; Gerald Antoch; Lino M Sawicki
Journal:  Eur Radiol       Date:  2021-04-28       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.